sucralfate

Brand: Carafate

Prototype Drug
Drug Class: cytoprotective agent
Drug Family: GI agent
Subclass: aluminum sucrose octasulfate (mucosal barrier)
Organ Systems: gastrointestinal

Mechanism of Action

Forms viscous gel at pH <4; binds positively charged proteins in ulcer base creating protective barrier against pepsin and bile; stimulates prostaglandins and bicarbonate secretion.

ulcer base — forms protective barrier

Indications

  • duodenal ulcer treatment and prevention
  • NSAID-induced ulcer
  • stress ulcer prophylaxis (ICU)
  • esophagitis

Contraindications

  • severe renal impairment (aluminum accumulation)

Adverse Effects

Common

  • constipation
  • dry mouth
  • nausea

Serious

  • aluminum toxicity (dialysis patients)
  • bezoar formation (rare)

Pharmacokinetics (ADME)

Absorption 3-5% absorbed systemically
Distribution minimal
Metabolism minimal
Excretion renal (aluminum)
Half-life 6-20 hours
Onset 30-60 min
Peak 30-60 min
Duration 6 hours
Protein Binding minimal
Vd minimal

Drug Interactions

Drug / Agent Mechanism Severity
fluoroquinolones/tetracyclines binds and chelates — take 2 hours apart major
warfarin may reduce warfarin absorption moderate
digoxin reduces digoxin absorption — separate by 2h moderate

Nursing Considerations

  1. Give 1 hour before meals and at bedtime on EMPTY STOMACH (acid pH needed for gel formation)
  2. Separate from other medications by 1-2 hours (chelates many drugs)
  3. Avoid in dialysis patients (aluminum accumulation — encephalopathy risk)
  4. Not absorbed systemically — safe in pregnancy

Clinical Pearls

  • Mechanism requires acid: must take on empty stomach before meals
  • Physical barrier rather than acid suppression — preferred when acid suppression contraindicated

Safety Profile

Pregnancy generally-safe
Lactation generally-safe
Renal Adjustment Required
Hepatic Adjustment Not required
TDM Not required

Concordance Terms

Cross-referenced clinical concepts — click any term to see all content where it appears.